Skip to main content

Table 1 Clinical characteristics of subjects in this study

From: The effects of BAFF on T lymphocytes in chronic obstructive pulmonary disease

 NonsmokerSmokerCOPD
Subjects163642
Age yrs58.6 ± 2.260.2 ± 1.163.7 ± 1.2
Male16(100%)36(100%)42(100%)
Smoking index p.y047.8 ± 4.348.6 ± 4.0
BMI kg/m223.1 ± 0.523.0 ± 0.322.1 ± 0.3
FVC % pred108.3 ± 3.5114.2 ± 2.590.6 ± 2.8**
FEV1/FVC%81.0 ± 1.377.3 ± 1.052.0 ± 2.0**
FEV1% pred109.7 ± 3.2109.2 ± 2.661.1 ± 3.5**
  1. Values are numbers (%) or mean ± SEM; COPD Chronic Obstructive Pulmonary Disease, p.y pack-yrs, BMI body mass index, FVC forced vital capacity, FEV1 forced expiratory volume in 1 sec, % pred % predicted; **: P < 0.01 versus nonsmoker and smoker